Harvard Bioscience Inc Stock (HBIO) Forecast
The Harvard Bioscience Inc (HBIO) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $4.41, representing a -53.57% decrease from the current price of $9.50. The highest analyst price target is $8.38, and the lowest is $0.4434.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
Is Harvard Bioscience Inc (HBIO) A Buy Now?
According to our latest analysis, HBIO could be considered a Strong Buy, with 17 technical analysis indicators signaling 13 Buy signals, 0 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on HBIO, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 64.95 indicates that HBIO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 62.99 indicates that HBIO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 65.24 indicates that HBIO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of 32.95 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of 110.19 indicates that HBIO is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term HBIO price forecast for 2026, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Harvard Bioscience Inc financial reports and earnings history, Harvard Bioscience Inc (HBIO) stock could reach $21.91 by 2030, $90.54 by 2040 and $256.47 by 2050. See the projected annual prices until 2050 of the Harvard Bioscience Inc stock below:
- Harvard Bioscience Inc (HBIO) is expected to reach an average price of $37.75 in 2035, with a high prediction of $41.04 and a low estimate of $33.66. This indicates an +297.41% change from the last recorded price of $9.50.
- Harvard Bioscience Inc (HBIO) stock is projected to chart a bullish course in 2040, with an average price target of $71.50, representing an +652.60% change from its current level. The forecast ranges from a conservative $69.12 to a sky-high $90.54.
- Our analysts predict Harvard Bioscience Inc (HBIO) to change +1,265% by 2045, soaring from $129.87 to an average price of $129.68, potentially reaching $187.41. While $129.87 is the low estimate, the potential upside is significant.
- Harvard Bioscience Inc (HBIO) stock is expected to climb by 2050, reaching an average of $222.97, a +2,247% change from its current level. However, a wide range of estimates exists, with high and low targets of $256.47 and $222.03, respectively, highlighting the market's uncertainty.
Harvard Bioscience Inc Stock (HBIO) Year by Year Forecast
Harvard Bioscience Inc Stock (HBIO) Price Forecast for 2026
The predicted value for Harvard Bioscience Inc (HBIO) in 2026 is set at an average of $6.29. Estimates vary from a peak of $16.48 to a trough of $0.4383, indicating an -33.82% surge from the present price of $9.50.
Harvard Bioscience Inc Stock (HBIO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Harvard Bioscience Inc (HBIO) is $17.01, with a high forecast of $30.22 and a low forecast of $0.7603. This indicates an +79.07% increase from the last price of $9.50.
Harvard Bioscience Inc Stock (HBIO) Price Forecast for 2028
In 2028, Harvard Bioscience Inc (HBIO) is projected to reach an average price of $12.12, with a high projection of $28.18 and a low estimate of $0.3995. This indicates an +27.56% rise from the last price of $9.50.
Harvard Bioscience Inc Stock (HBIO) Price Forecast for 2029
The 2029 price forecast for Harvard Bioscience Inc Stock (HBIO) is $4.50 on average, with a high prediction of $14.93 and a low estimate of $0.0819. This represents an -52.62% decrease from the previous price of $9.50.
Harvard Bioscience Inc Stock (HBIO) Price Forecast for 2030
Harvard Bioscience Inc Stock (HBIO) is expected to reach an average price of $14.22 in 2030, with a high forecast of $21.91 and a low forecast of $5.08. This signifies an +49.72% surge from the last price of $9.50.